Skip to main content
. 2011 Jun 1;52(11):1332–1341. doi: 10.1093/cid/cir228

Table 4.

Distribution and Association of CD14 -159 C > T and -4191 C > T Single Nucleotide Polymorphism (SNP) Genotypes and Alleles With the Identification of Enteric Pathogens

Variable Enteropathogen identified, no. of positive specimens/no. of stool specimens tested
Healthy subjects Bacterial pathogen EAEC ETEC EPEC STEC EIEC
CD14-159 C > T (n = 959) n = 496 n = 178/294 n = 110/292 n = 117/289 n = 70/163 n = 18/162 n = 14/163
    Genotype
C/C n =247 134 (27.0) 34 (19.1) 20 (18.2) 22 (18.8) 15 (21.4) 3 (16.7) 6 (42.6)
    C/T n =440 240 (48.4) 83 (46.6) 48 (43.6) 55 (47.0) 33 (47.1) 8 (44.4) 4 (28.6)
    T/T n =272 122 (24.6) 61 (34.3) 42 (38.2) 40 (34.2) 22 (31.4) 7 (38.9) 4 (28.6)
    P .01a .009a .05a .39a .38a .29a
    TT status
    Non-TT (n =687) 374 (75.4) 117 (65.7) 68 (61.8) 77 (65.8) 48 (68.6) 12 (63.2) 10 (71.4)
    TT (n =272) 122 (24.6) 61 (34.3) 42 (38.2) 40 (34.2) 22 (31.4) 7 (36.8) 4 (28.6)
        RR (95% CI) 1.40 (1.0–1.80) 1.66 (1.18–3.32) 1.45 (1.03–2.01) 1.34 (0.86–2.12) 1.74 (0.72–4.21) 1.30 (0.41–3.60)
    P .01b .006b .03b .24b .27b .75b
    Allele
    C (n =1008) 508 (51.2) 151 (42.4) 88 (40.0) 99 (42.3) 63 (45.0) 14 (38.9) 16 (57.1)
    T (n =910) 484 (48.8) 205 (57.6) 132 (60.0) 135 (57.7) 77 (55.0) 22 (61.1) 12 (42.9)
        RR (95% CI) 1.3 (1.08–1.56) 1.45 (1.14–1.85) 1.34 (1.06–1.70) 1.24 (0.91–1.70) 1.62 (0.85–3.10) 0.79 (0.38–1.63)
    P .004b .003b .01b .17b .17b .57b
CD14-4191 C > T (n = 897) n = 459 n = 166/294 n = 93/291 n = 92/291 n = 60/135 n = 15/134 n = 13/135
    Genotype
    CC (n =538) 255 (55.6) 111 (66.9) 68 (73.1) 63 (68.5) 43 (71.7) 8 (53.3) 7 (53.8)
    CT (n =310) 170 (37.0) 50 (30.1) 22 (23.7) 28 (30.4) 14 (23.3) 6 (40.0) 4 (30.8)
    TT (n =49) 34 (7.4) 5 (3.0) 3 (3.2) 1 (1.1) 3 (5.0) 1 (6.7) 2 (15.4)
    P .01a .006a .01a .07a .97a .54a
    CC status
    CC (n =538) 255 (55.6) 111 (66.9) 68 (73.1) 63 (68.5) 43 (71.7) 8 (53.3) 7 (53.8)
    Non-CC (n =359) 204 (44.4) 55 (33.1) 25 (26.9) 29 (31.5) 17 (28.3) 7 (46.7) 6 (46.2)
        RR (95% CI) 0.70 (0.5–0.98) 0.52 (0.34–0.79) 0.63 (0.42–0.94) 0.53 (0.31–0.90) 1.09 (0.40–2.95) 1.06 (0.36–3.13)
    P .01b .002b .03b .02b 1b 1b
    Allele
    C (n =1386) 680 (74.1) 272 (81.9) 158 (84.9) 154 (83.7) 100 (83.3) 22 (73.3) 18 (69.2)
    T (n =408) 238 (25.9) 60 (18.1) 28 (15.1) 30 (16.3) 20 (16.7) 8 (26.7) 8 (30.8)
        RR (95% CI) 0.70 (0.55–0.90) 0.56 (0.38–0.81) 0.61 (0.42–0.84) 0.64 (0.38–0.96) 1.04 (0.47–2.30) 1.26 (0.36–2.86)
     P .004b .001b .005b .03b .92b .6b

NOTE. CI, confidence interval; EAEC, Enteroaggregative Escherichia coli; EIEC, Enteroinvasive E. coli; EPEC, Enteropathogenic E. coli; ETEC, Enterotoxigenic E. coli (producing ST, LT, or LT/ST); RR, relative risk; STEC, Shiga toxin–producing E. coli.

a

3 × 2 χ2 test, for comparing with enteropathogens versus healthy control subjects.

b

2 × 2 χ2 test, for comparing with enteropathogens versus healthy control subjects.